Gain of the q arm of chromosome 20 in human colorectal cancer has been associated with poorer survival time and has been reported to increase in frequency from adenomas to metastasis. The increasing frequency of chromosome 20q amplification during colorectal cancer progression and the presence of this amplification in carcinomas of other tissue origin has lead us to hypothesize that 20q11-13 harbors one or more genes which, when over expressed promote tumor invasion and metastasis. AIMS: Generate genomic and expression profiles of the 20q amplicon in human cancer cell lines in order to identify genes with increased copy number and expression. MATERIALS AND METHODS: Utilizing genomic sequencing clones and amplification mapping data from our lab and other previous studies, BAC/ PAC tiling paths spanning the 20q amplicon and genomic microarrays were generated. Array-CGH on the custom array with human cancer cell line DNAs was performed to generate genomic profiles of the amplicon. Expression array analysis with RNA from these cell lines using commercial oligo microarrays generated expression profiles of the amplicon. The data were then combined in order to identify genes with increased copy number and expression. RESULTS: Over expressed genes in regions of increased copy number were identified and a list of potential novel genetic tumor markers was assembled based on biological functions of these genes CONCLUSIONS: Performing high-resolution genomic microarray profiling in conjunction with expression analysis is an effective approach to identify potential tumor markers.
sion and metastasis. [1, 2] Characterization of genomic rearrangements is, therefore, a major area of investigation being pursued by the cancer research community.
Amplification of genomic DNA is one such form of rearrangement that leads to an increase in the copy number of specific genes frequently detected in a variety of human cancer cell types. Our laboratory has been interested in characterizing amplified genomic regions in cancer cells based on the hypothesis that these segments harbor critical genes associated with initiation and/ or progression of cancer. Gain of chromosome 20q in human colorectal cancer has been associated with poorer survival time and has been reported to increase in frequency from around 50% in adenomas, to 60% in early carcinomas and to 83% in late carcinomas and liver metastasis. [3, 4, 5] The increasing frequency of chromosome 20q amplification during colorectal cancer progression and the presence of this amplification in carcinomas of diverse origins has lead us to hypothesize that the 20q11-13 amplicon harbors one or more amplified genes which, when over expressed promote tumor invasion and metastasis. In view of this hypothesis we were interested to generate high-resolution amplification profiles for human chromosome 20q in colorectal cancer cell lines by microarray comparative genomic hybridization (array-CGH) and correlate the results with expression microarray analysis to identify novel amplified and over expressed genes whose function suggest an association with tumor invasion/metastasis.
Material and Methods
Cell Lines probe. Probes with a signal to noise ratio less than 3
were excluded.
Results

MCF7 and SKBr3 breast carcinoma cell lines have
been extensively characterized in the 20q region and were used to validate the quality and accuracy of the custom genomic arrays. [9, 10] Array-CGH was performed on these cell lines using the initial 12 Mb BAC/PAC ge- The profiles generated from array-CGH analysis agreed well with the profiles previously generated by array 1
[ Figure 2 ]. While MCF7 showed no copy gain over the extended contig, SKBr3's profile from array 2 showed the same copy gains as that of array 1's profile. In the extended amplicon region, SKBr3 showed copy gain extended from 42Mb to 46Mb and identified a high copy gain from 37Mb to 38Mb. Array-CGH was then carried out with DNA from the colorectal carcinoma cell lines HT29 and CaCo-2 DNA on the second array [ Figure 3 ].
The profiles generated reveal differential copy number variation across the 20q amplicon for both cell lines.
Cell line HT29 showed an overall copy gain of 1(log 2 ratio = 0.5) with regions of amplification at 37-39 Mb, 42-45Mb, 50-53Mb and 54-56Mb. There is also a very distinct high-level amplification of +3 copies (total copy number =5) at 54Mb. CaCo-2's genomic profile was very complex, showing an average copy gain of 2 (log 2 ratio = 1) with specific regions of amplification of +2.5 (log 2 ratio =1.25) at 49Mb, 51Mb, 54Mb and 55.5Mb. Amplifications of +3 copies (log 2 ratio= 1.5) were seen at 39Mb, 41Mb, 44Mb, 45Mb. One region of high amplification with a copy number of +4 (log 2 ratio =2) was observed at 43Mb. Regions along 20q that displayed copy gain in both the cell lines were identified as folGenomic and expression array profiling of cancer amplicon tive genomic hybridization to arrayed genomic clones affords a higher resolution and broader examination of genomic regions than previously available. [16] Using the BAC/PAC genomic microarray to scan for amplification has afforded an increased sensitivity necessary to provide a high-resolution map of the 20q amplicon detected in the colorectal cancer cell lines, we examined. The validation experiments with breast carcinoma cell lines MCF7 and SKBr3, when compared with previous studies, provided mixed results. [9, 10] For SKBr3, the genomic profile generated with both array 1 and array 2 were consistent and agreed with regions of amplification previously identified using FISH [9] and BAC array-CGH. [10] However, although MCF7's genomic profile was consistent from array 1 to array 2 and agreed with the previous FISH study, [9] the profile was not consistent with that seen in the previous BAC array-CGH study. [10] The difference in the profiles generated could be due to the documented high variation in MCF7 cell lines from different sources. [17] Our source for MCF7 was ATCC, and based on their karyotype information as well as that previously published, MCF7 has been reported with a range of chromosome 20 copy number, from being nullisomic to polysomic. [17, 18] The profile generated with our genomic array is consistent with that reported in the SKY, FISH, CGH database on The University of Cambridge Cancer Genomics Program website.
[19]
The genomic profiles for HT29 and CaCo-2 revealed an overall increase of one and two copies of chromosome 20q respectively, which is in agreement with previous karyotyping and metaphase CGH studies. [20, 21] However, with the custom array-CGH we were able to detect further regional gains at the 37-39Mb, 42-45Mb, 48-50Mb, and 52-56Mb intervals. The HT29 profile also reveals a distinct copy gain at 53Mb, while CaCo-2 appears to have a distinct copy gain at 43Mb. Overall, HT29's profile shows fewer distinct copy gains while
CaCo-2 appears to have multiple distinct copy gains.
When these genomic profiles were combined with ex- increasing resistance to apoptosis in cancer cells. [22] The candidate genes MYBL2 and UBE2C are directly involved in cell cycle progression through the promotion of G1 to S phase and the degradation of cyclins as part of the APC2 complex respectively, thus their importance in cancer cells has been previously noted. [23, 24] According to a previous study, the protein encoded by ADNP may increase the viability of certain cell types through modulation of p53 activity, thus making it a very attractive oncogene candidate as well. [25] YWHAB coeds for the protein 14-3-3 beta, which is involved in mediating signal transduction as well as having been shown to promote cell spreading and migration through it's interaction with beta-1 integrin. [26] Thus it is likely that over In one published study, the chaperonin protein coded for by PFDN4 showed cell cycle specific expression and was highly expressed in cells in crisis, suggesting that PFDN4 may play an important role in cell cycle regulation and overcoming senescence [27] . Interestingly, the highly amplified region at 43Mb in CaCo-2 did not contain a candidate gene, but MYBL2 and YWHAB flank this region and could be affected by this amplification.
Utilizing both array-CGH and expression array analysis, a list of over 200 potential candidate genes represented on the arrays was efficiently reduced to 10 candidate genes for further examination. Other commonly amplified genomic regions in colon and breast tumors include 8p11-12, 17q23 and 12q13-14 [14, 28, 29] . In utilizing microarray technology, identification of amplicon genes contributing to tumor progression can be done in a genome wide, efficient manner. These genes could serve to identify the cellular pathways commonly altered in human cancer and signify which profiles are associated with certain tumor phenotypes. The genes identified could also be used as a panel of tumor markers for diagnosis, prognosis as well as identification of targets for drug therapy effective in the treatment of tumors.
